CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Inno-Gene SA Company Snapshot
Inno-Gene SA operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Inno-Gene SA with three other miscellaneous service companies in Europe: Physiomics PLC of UNITED KINGDOM (2020 sales of £799,055.00 [US$1.09 million] of which 100% was Outsourced Systems and Computational Bio), Genomic Vision Sa of FRANCE (1.08 million Euros [US$1.26 million] ), and Sequana Medical NV which is based in BELGIUM (963,280.00 Euros [US$1.12 million] of which 100% was Group).

Sales Analysis. Sales were up sharply during the second quarter of 2021 versus the previous year's second quarter. During the second quarter of 2021, sales at Inno-Gene SA totalled 10.96 million Polish New Zlotys. This is an increase of 848.2% from the 1.16 million Polish New Zlotys in sales at the company during the second quarter of 2020. During the first two quarters of 2021, sales totalled 12.46 million Polish New Zlotys, which is 801.1% higher than through the first two quarters of 2020. Sales increased substantially in 2020: During the year ended December of 2020, sales at Inno-Gene SA were 4.68 million Polish New Zlotys (US$1.19 million). This is an increase of 244.8% versus 2019, when the company's sales were 1.36 million Polish New Zlotys.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Inno-Gene SA
  Stock Performance Chart for Inno-Gene SA
 
  Stock Data: Recent Stock Performance:
  Current Price (10/8/2021): 9.70
(Figures in Polish New Zlotys)
1 Week -4.0%   13 Weeks -3.1%  
4 Weeks -0.4%   52 Weeks -88.8%  
 
Inno-Gene SA Key Data:
  Ticker: IGN Country: Poland
  Exchanges: WAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 4,679,062
(Year Ending Jan 2021).
Employees: 16
  Currency: Polish New Zlotys Market Cap: 55,271,980
  Fiscal Yr Ends: December Shares Outstanding: 5,701,081
  Share Type: Akcje Closely Held Shares: 2,344,379
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.